Monitoring the radioimmunotherapeutic effect by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.

Slides:

Advertisements

Similar presentations

An Intergroup Randomised Trial of Rituximab versus a Watch & Wait Approach in Patients with Advanced Stage, Asymptomatic, Non-bulky Follicular Lymphoma.

Advertisements

Consensus or Controversy? Investigator Perspectives on Practical Issues and Research Questions in Non-Hodgkin Lymphoma Friday, December 6, :00 PM.

18F- FDG PET/CT in the Diagnosis of Tumor Thrombosis

Case Report # 1 Submitted By: Samuel Oats, MSIV Radiological Category: Body Principal Modality (1): Principal Modality (2): PET/CT CT Faculty Reviewer:

Enisa Zaric, MD Montenegro Specialist

Advances in Nuclear Medicine and its Impact on Diagnosis and Management of GI Cancers Medhat Osman, MD PhD Philip Alderson, MD.

CASE HISTORY #1 AIBD Breakout Session Douglas C. Wolf, M.D.

Dual-time point 18F-FDG PET/CT scan: is it always working?

HYBRID IMAGING.  Combination  Nuclear medicine  Radiology  PET/CT  Positron emission tomography  Computed tomography  SPECT/CT  Single photon.

Early diagnosis of ischemic osteonecrosis of femoral head in bone SPECT/CT imaging Kaohsiung Veterans General Hospital Nan-Jing Peng.

Early detection of a colon cancer on health screening by PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.

Unexpected additional lung cancer in a patient with already known inflammatory myofibroblastic tumor detected on PET/CT Kaohsiung Veterans General Hospital.

Early detection of an endometrial cancer on health screening by PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.

FDG PET/CT case report early detection of ovarian cancer NM case conference, chairman: Nan-Jing Peng, MD.

Incidentally find an adrenal tumor on health screening by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.

WELCOME. PET/CT CASE REVIEW COURSE JANUARY 31 ST PASADENA CONVENTION CENTER LOS ANGELES RADIOLOGIC SOCIETY MID WINTER MEETING.

Unexpected additional thyroid cancer in a patient with already known cervical cancer detected on PET/CT Kaohsiung Veterans General Hospital Kuan-Hsiu Lin,

Moskowitz CH et al. Proc ASH 2014;Abstract 673.

CHONBUK NATIONAL UNIVERSITY HOSPITAL Great Day to you! CHON BUK NATIO NAL UNIVE RSITY HOSPI TAL GIM BYUNG CHUL The Change on PET/CT Image of Patients with.

Childhood Hodgkin Lymphoma Cases and Controversies Eurasian Commonwealth Online Conference 5/25/05 Scott Howard, MD, MSc St. Jude Children’s Research Hospital.

A new possible conditionning regimen before Autologous Stem Cell Transplantation for refractory high-grade lymphoma Z-BeEAM (Ibritumomab tiuxetan, Bendamustine,

Multiple Myeloma: 18F-FDG-PET/CT and Diagnostic Imaging

Bronchoscopy-Guided Cooled Radiofrequency Ablation as a Novel Intervention Therapy for Peripheral Lung Cancer Respiration 2015;90: DOI: /

Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell.

A 71-year-old male with mantle cell lymphoma presenting with bright red blood per rectum. Dynamic images of the abdomen and pelvis were obtained in the.

Hugo J.A. Adams, Rutger A.J. Nievelstein, Thomas C. Kwee Blood Reviews

Fig FDG PET-CT and diagnostic contrast-enhanced chest CT in patient with angioimmunoblastic T-cell lymphoma. MIP image (A) demonstrates intense 18FDG.

How I treat extramedullary myeloma

High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Primary Central Nervous System Lymphoma (PCNSL) in First Complete Remission (CR1)

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease Eisaku.

The Effect of Statin Use at the Time of Autologous Transplant on Response and Survival in Multiple Myeloma Mehdi Hamadani, Erinn Hade, Don M. Benson,

Outcomes of Diffuse Large B-Cell Lymphoma (DLBCL) Patients Progressing after Autologous Hematopoietic Stem Cell Transplant Maria Gil-Cupello, BA, Gunjan.

Figure 5 Number of AHSCT procedures for

Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin.

Primary CNS Lymphoma—Radiation-Free Salvage Therapy by Second Autologous Stem Cell Transplantation Benjamin Kasenda, M.D., Elisabeth Schorb, M.D., Kristina.

Primary chest wall lymphoma with no history of tuberculous pyothorax: Diagnosis and treatment Abbas Tabatabai, MD, Mozaffar Hashemi, MD, Mojtaba Ahmadinejad,

Predictive Value of Pre-Transplant PET/CT Scan before Autologous Stem Cell Transplant in Mantle Cell Lymphoma Brian Hess, MD, Kathryn Trinkaus, Ph.D.,

The Impact of the Host on Fungal Infections

Hematopoietic Stem Cell Transplantation for Refractory or Recurrent Non-Hodgkin Lymphoma in Children and Adolescents Thomas G. Gross, Gregory A. Hale,

Routine Pre- and Post-Hematopoietic Stem Cell Transplant Computed Tomography of the Abdomen for Detecting Invasive Fungal Infection Has Limited Value

Autologous Peripheral Blood Stem Cell Transplantation in Children with Refractory or Relapsed Lymphoma: Results of Children’s Oncology Group Study A5962

Analysis of the Prognostic Effect of Peripheral Blood Lymphocyte and Monocyte Count after Autologous Hematopoietic Stem Cell Transplant in Refractory/Relapsed.

Case Report: 52 Year-Old Male 11 Months after MUD for Angionimmunoblastic T Cell Lymphoma Developed Acute Fibrinous Organizing Pneumonitis Successfully.

Estrogen Receptor (ER) and Epidermal Growth Factor Receptor (EGFR) as Targets for Dual Lung Cancer Therapy: Not Just a Case? Monica Giovannini, MD, Carmen.

Evidence of a Graft-versus-Hodgkin Lymphoma Effect in the Setting of Extensive Bone Marrow Involvement Paolo Anderlini, MD Biology of Blood and Marrow.

Elotuzumab in Combination with Lenalidomide and Dexamethasone for Treatment- resistant Immunoglobulin Light Chain Amyloidosis With Multiple Myeloma Shumaila.

Rapid onset of CD8+ aggressive T-cell lymphoma during bexarotene therapy in a patient with Sézary syndrome Alexander Kreuter, MD, Peter Altmeyer, MD

Outcomes of Diffuse Large B-Cell Lymphoma (DLBCL) Patients Progressing after Autologous Hematopoietic Stem Cell Transplant Maria Gil-Cupello, BA, Gunjan.

Clinical responses in patients.

Early Toxicities Associated with Radiation Based Conditioning for Relapsed/Refractory Hodgkin Lymphoma Patients Undergoing High Dose Therapy and Autologous.

Controversies in Lymphoma: The Role of Hematopoietic Cell Transplantation for Mantle Cell Lymphoma and Peripheral T Cell Lymphoma Peter Dreger, Ginna.

Metabolic response by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT). a) FDG PET/CT for patient 2 at baseline.

The International Prognostic Index Assessed at Relapse Predicts Outcomes of Autologous Transplantation for Diffuse Large-Cell Non-Hodgkin’s Lymphoma in.

Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib Oana Pop, MD, Augustin Pirvu,

Kamal Kant Singh Abbi, Junting Zheng, Sean M

A 79-Year-Old Woman With Bilateral Cavitating Lung Nodules

Results of 10-Year Single Center Experience with Pharmacokinetics Directed Intravenous Busulfan, Cyclophosphamide and Etoposide Preparative Regimen in.

Single Center Experience with High Dose Melphalan and Two Day Washout in Patients with Multiple Myeloma on Hemodialysis Undergoing Autologous Stem Cell.

Axillary Mass and Hypercalcemia: The Value of a Physical Examination

Incidence of Adrenal Insufficiency in Patients with Multiple Myeloma during High Dose Chemotherapy and Autologous Stem Cell Transplant Ahmad Hatem Mattour,

Second Autologous Stem Cell Transplantation as Salvage Therapy for Multiple Myeloma: Impact on Progression-Free and Overall Survival Victor H. Jimenez-Zepeda,

Siddharth Singh, Matthew T. Howard, Konstantinos A. Papadakis

Volume 10, Pages 1-4 (December 2016)

Management of Cytokine Release Syndrome (CRS) in Patients Undergoing Chimeric Antigen Receptor Modified (CAR) T-Cell Therapy Following Autologous Stem.

High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosis C.G. Steward,

An algorithmic approach to FL

Long-Term Results Of Autologous Hematopoietic Cell Transplantation For Peripheral T Cell Lymphoma: The Stanford Experience Andy I. Chen, Alex McMillan,

by Lapo Alinari, and Kristie A. Blum

Optimizing therapy for nodal marginal zone lymphoma

Case discussions ICEOS 2009 Istanbul Jack Flynn, MD

Presentation transcript:

Monitoring the radioimmunotherapeutic effect by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine

 Abstract: A case of non-Hodgkin's lymphoma s/p OP, C/T, R/T, and autologous peripheral blood stem cell transplantation with tumor recurrence s/p 1st R- ProM ACECytaBOM on 2006/8/25 and 8/27, 2nd R-ProMACECytaBOM on 9/2 and 9/3 s/p Rituximab 550mg on 11/3. PET/CT showed lymphoma with multiple FDG- avid lesions in chest and abdomen. Two months after 32 mCi Zevalin/Ytracis therapy, repeated PET/CT showed remission of supradiaphragmatic lesions but left orbital fossa and subdiaphragmatic lesions in progress.

PET/CT before Zevalin 54 y/o male non-Hodgkin's lymphoma Figure 1 PET/CT 2 months after Zevalin